The Balancing Act<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />2/27/2008 8:45 AM EST<br /><br />Consistency is the last refuge of the unimaginative. <br />-- Oscar Wilde<br /> <br /> <br />One of the biggest challenges for investors in the current market environment is trying to reconcile our view of the economy with the action in the market. It has been more tricky than usual lately, as a steady flow of negatives are being ignored while the market celebrates questionable positives, such as a deal for bond insurers and an increase in IBM (IBM) estimates of less than 1%. <br /><br />The dollar is reaching record lows; oil, gold and commodities are hitting record highs; signs of inflation grow; more bad debt write-offs emerge; and housing prices erode at an accelerated pace -- yet the market holds up fairly well. How does an investor reconcile this poor news flow with fairly good market action? <br /><br />Either we have to believe the market has already priced in all these negatives or that it is enjoying some short-term denial. The difficulty is that the best course of action for investors usually is to defer to the price action. In the long run, it never pays to argue with a market that isn't doing what you think it should do, but in the short term, seemingly irrational market action is much more difficult to handle. <br /><br />There is no easy way to deal markets that are acting contrary to how you think they should. If you are too stubborn and hold on to your convictions you risk being buried as a new trend emerges, but if you are too wishy-washy and react to minor day-to-day movements, you will miss out on profiting from insights. <br /><br />While we want to have conviction in the face of contrary action, we don't want to be obstinate should things not play out the way we believe. To accomplish that, we have to have some lines in the sand. We have to admit we are wrong and cut our losses if the market continues to act contrary to what we feel. We can always re-enter our trades, but conviction is a very dangerous thing in a market that is often quite irrational. <br /><br />I feel quite strongly that the market has more downside to come. I simply don't see how all the fundamental negatives and uncertainties can be priced into this market. However, I also recognize that within a larger downtrend, we are going to have some good rallies, and I need to be flexible enough to profit from them when they occur. In addition, at some point a major turn will come, and I have to make sure I'm not overly stubborn in embracing a real change in the market. <br /><br />When I look at the charts of the major indices, I see a clear downtrend with some typical relief rallies. Nothing that has happened is sufficient to make me feel that my embrace of bigger downtrend is wrong at this point. I'll stay open-minded and will continue to respect the price action of the market, but days like yesterday aren't sufficient to turn me into a bull. <br /><br />We have a weak start this morning. I'm still short some indices from yesterday and will make some partial covers into this weakness.<br /><br /><br />---------------------------<br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: ADSK -13.0% (also downgraded to Hold at Needham and downgraded to Accumulate at ThinkEquity), DY -8.8%, LAMR -8.7%, NT -8.3%, URS -7.1%, CRI -6.5%, ESST -5.9%, DRC -5.3%, BTUI -5.1%, APSG -4.8%, FNM -4.5%, DYN -4.4%, OSG -4.3%, CVTX -3.6%, IHP -3.1%, BMRN -2.9%, BID -2.8%, RRC -2.7%, TX -2.6%, SQM -2.1%, SCRX -1.7%, MGA -1.4%, ORA -1.4%... Select solar stocks showing weakness following multiple downgrades: JASO -8.1% (downgraded to Neutral at BofA), SOLF -6.6% (downgraded to Sell at BofA), TSL -5.0% (downgraded to Sell at BofA), YGE -4.7% (downgraded to Neutral at BofA), LDK -1.5%, ESLR -1.4%, FSLR -1.2%... Select agriculture names showing weakness: CF -2.6%, TRA -2.5%, MOS -2.3%, AGU -2.2%, POT -2.2%, MON -1.8%... Other news: RJA -4.7% (still checking), EEP -3.8% (announces an offering of ~4 mln of its Class A common units), FRE -2.9% (down in sympathy with FNM), CF -2.9% (reports outage at its Medicine Hat, Alberta Nitrogen complex), ENS -2.7% (registers to sell 5 mln shares of common stock for holders), DAL -2.6% (CEO Anderson says no merger agreement yet with Northwest Air), AZN -2.2% (stopping study on the experimental cancer drug Recentin - DJ), KMP -1.9% (files for a 4.3 mln common unit secondary offering), JPM -1.4% (estimates cut at Citigroup), AMGN -1.6% and JNJ -1.1% (anemia drugs have blood clot, death risk, according to study - DJ)... Analyst downgrades: COST -2.2% (hearing downgraded to Neutral at tier 1 firm).<br /><br />